| RS1064796541 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1064796542 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 1, Cystic renal disease |
| RS1064796543 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1064796545 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS1064796547 |
SYNGAP1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1064796549 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS1064796552 |
DPYD
|
Health Risk |
Likely pathogenic |
— |
| RS1064796556 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1064796557 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS1064796564 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1064796565 |
KIF1A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory |
| RS1064796568 |
NSD1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064796569 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064796572 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064796574 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064796579 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1064796581 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS1064796583 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1064796584 |
KCNH2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796593 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS1064796601 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1064796606 |
TCOF1
|
Health Risk |
Pathogenic |
— |
| RS1064796608 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1064796609 |
NAXE
|
Health Risk |
Pathogenic |
— |
| RS1064796610 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796611 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1064796614 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS1064796615 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1064796617 |
EZH2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796618 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1064796620 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796622 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1064796630 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1064796631 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1064796632 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1064796633 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1064796635 |
LAMP2
|
Health Risk |
Likely pathogenic |
Melanoma, Nonpapillary renal cell carcinoma |
| RS1064796636 |
FBN1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064796640 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796644 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796646 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS1064796648 |
ATP7A
|
Health Risk |
Likely pathogenic |
Menkes kinky-hair syndrome, Menkes kinky-hair syndrome |
| RS1064796649 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796656 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS1064796658 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1064796660 |
COL2A1
|
Health Risk |
Pathogenic |
Type 2 collagenopathy, Type 2 collagenopathy |
| RS1064796665 |
MNX1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796666 |
CHD8
|
Health Risk |
Likely pathogenic |
— |
| RS1064796667 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064796669 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS1064796670 |
COL12A1
|
Health Risk |
Pathogenic |
COL12A1-related disorder, COL12A1-related disorder |
| RS1064796672 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1064796673 |
EFEMP2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796675 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS1064796677 |
LMNA
|
Health Risk |
Pathogenic |
— |
| RS1064796681 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Li-Fraumeni syndrome |
| RS1064796683 |
B4GALT7
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome progeroid type, Ehlers-Danlos syndrome progeroid type |
| RS1064796684 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1064796690 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796691 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1064796693 |
KIF1C
|
Health Risk |
Likely pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS1064796698 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1064796700 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1064796702 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1064796703 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1064796706 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1064796708 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS1064796709 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1064796710 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 54 |
| RS1064796711 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1064796712 |
SMARCE1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796713 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1064796714 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1064796715 |
ERF
|
Health Risk |
Pathogenic/Likely pathogenic |
TWIST1-related craniosynostosis, TWIST1-related craniosynostosis |
| RS1064796717 |
NARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796718 |
SOX9
|
Health Risk |
Likely pathogenic |
— |
| RS1064796720 |
STXBP1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS1064796721 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS1064796722 |
TP53
|
Health Risk |
Likely pathogenic |
Ovarian neoplasm, Li-Fraumeni syndrome 1 |
| RS1064796723 |
MEIS2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796724 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064796729 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1064796731 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796732 |
ELAC2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796733 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796738 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1064796741 |
VCP
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064796742 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS1064796744 |
NIPBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1064796745 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Inborn genetic diseases |
| RS1064796748 |
KRAS
|
Health Risk |
Pathogenic |
— |
| RS1064796750 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS1064796752 |
GRIN2B
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1064796754 |
IDUA
|
Health Risk |
Likely pathogenic |
— |
| RS1064796756 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Inborn genetic diseases |
| RS1064796757 |
CLPB
|
Health Risk |
Likely pathogenic |
— |
| RS1064796758 |
WAC
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064796759 |
DDX3X
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1064796760 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064796761 |
ADAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |